Cargando…

Updated guidelines for the management of dyslipidemia and the prevention of cardiovascular disease in adults by pharmacists

Detalles Bibliográficos
Autores principales:	Babadagli, Hazal E., Barry, Arden R., Thanassoulis, George, Pearson, Glen J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Research and Clinical
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186865/ https://www.ncbi.nlm.nih.gov/pubmed/37201165 http://dx.doi.org/10.1177/17151635231164989

Ejemplares similares

Omega-3 fatty acids for cardiovascular disease prevention: A practice tool for pharmacists
por: Barry, Arden R., et al.
Publicado: (2022)

Review of the top 5 cardiology studies of 2021-22
por: Barry, Arden R., et al.
Publicado: (2023)

Canadian Cardiovascular Harmonized National Guideline Endeavour (C-CHANGE) guideline for the prevention and management of cardiovascular disease in primary care: 2022 update
por: Jain, Rahul, et al.
Publicado: (2022)

Sick Individuals and Sick Populations by Geoffrey Rose: Cardiovascular Prevention Updated
por: Sniderman, Allan D., et al.
Publicado: (2018)

2016 Chinese guidelines for the management of dyslipidemia in adults
Publicado: (2018)

The approach of Iranian clinical pharmacists in the treatment of dyslipidemia based on international guidelines
por: Mirshekari, Mehrzad, et al.
Publicado: (2023)

Comparison of Preventive Cardiovascular Pharmacotherapy in Surgical vs Percutaneous Coronary Revascularization
por: Barry, Arden R., et al.
Publicado: (2019)

Practice guideline for pharmacists: The management of late-onset hypogonadism
por: Matai, Aakriti, et al.
Publicado: (2021)

2018 Guidelines for the management of dyslipidemia
por: Rhee, Eun-Jung, et al.
Publicado: (2019)

New guidelines and evidence for prevention and treatment of dyslipidemia and atherosclerotic cardiovascular disease in China()
por: Hu, Da-Yi
Publicado: (2016)

Management of diabetic dyslipidemia: An update
por: Jialal, Ishwarlal, et al.
Publicado: (2019)

Awareness of Physicians and Clinical Pharmacists About ACC/AHA Guidelines for Dyslipidemia Management: A Cross-Sectional Study
por: Zaitoun, Mohammad Fathullah, et al.
Publicado: (2019)

2018 Guidelines for the Management of Dyslipidemia in Korea
por: Rhee, Eun-Jung, et al.
Publicado: (2019)

2018 Guidelines for the management of dyslipidemia in Korea
por: Rhee, Eun-Jung, et al.
Publicado: (2019)

2022 Saudi Guidelines for the Management of Dyslipidemia
por: AlRahimi, Jamilah, et al.
Publicado: (2023)

2015 Clinical Practice Guidelines for the Management of Dyslipidemia in the Philippines - Executive Summary: Dyslipidemia Guidelines 2015
por: Guerrero, Adriel E.
Publicado: (2016)

Review of the top 5 cardiology studies of 2019-20
por: Barry, Arden R., et al.
Publicado: (2021)

American Association of Clinical Endocrinologists/American College of Endocrinology Management of Dyslipidemia and Prevention of Cardiovascular Disease Clinical Practice Guidelines
por: Jellinger, Paul S.
Publicado: (2018)

Time to consider an Asian guideline for management of dyslipidemia?
por: Yokote, Koutaro, et al.
Publicado: (2012)

Overview of guidelines for the management of dyslipidemia: EU perspectives
por: Giner-Galvañ, Vicente, et al.
Publicado: (2016)

Comparison of Current International Guidelines for the Management of Dyslipidemia
por: Aygun, Sevda, et al.
Publicado: (2022)

Dyslipidemia management for primary prevention of cardiovascular events: Best in-clinic practices
por: Thongtang, Nuntakorn, et al.
Publicado: (2022)

Update on dyslipidemia in hypothyroidism: the mechanism of dyslipidemia in hypothyroidism
por: Liu, Huixing, et al.
Publicado: (2022)

Canadian national consensus guidelines for naloxone prescribing by pharmacists
por: Tsuyuki, Ross T., et al.
Publicado: (2020)

Management of Dyslipidemia in Secondary Prevention of Cardiovascular Disease: The Gap between Theory and Practice
por: Santangelo, Gloria, et al.
Publicado: (2022)

Role of community pharmacists in cardiovascular diseases-related health promotion and dyslipidemia management in Malaysia: A nationwide cross-sectional study
por: Ismail, Farhana Fakhira, et al.
Publicado: (2023)

Updated Cardiovascular Prevention Guideline of the Brazilian Society of Cardiology - 2019
por: Précoma, Dalton Bertolim, et al.
Publicado: (2019)

Associations of dipping and non-dipping hypertension with cardiovascular diseases in patients with dyslipidemia
por: Dai, Siping, et al.
Publicado: (2018)

Perceptions of Independent Pharmacist Prescribing among Health Authority- and Community-Based Pharmacists in Northern British Columbia
por: Lewis, Jordan, et al.
Publicado: (2021)

Management Status of Cardiovascular Disease Risk Factors for Dyslipidemia among Korean Adults
por: Lee, Jongseok, et al.
Publicado: (2017)

Updates on dyslipidemia in patients with diabetes
por: Ide, Shintaro, et al.
Publicado: (2023)

The 2020 CCS atrial fibrillation guidelines for pharmacists: Top 10 takeaways
por: Leblanc, Kori, et al.
Publicado: (2021)

Amendment of the low-density lipoprotein cholesterol target in the ‘Chinese Guidelines for the Prevention and Treatment of Adult Dyslipidemia’: Opinion
por: Zhao, Shui-Ping
Publicado: (2016)

SASLT practice guidelines for the management of Hepatitis B virus – An update
por: Abaalkhail, Faisal A., et al.
Publicado: (2021)

European Guidelines for Obesity Management in Adults
por: Yumuk, Volkan, et al.
Publicado: (2015)

2015 Korean Guidelines for the Management of Dyslipidemia: Executive Summary (English Translation)
Publicado: (2016)

Executive Summary of the 2020 Clinical Practice Guidelines for the Management of Dyslipidemia in the Philippines
por: Gonzalez-Santos, Lourdes Ella, et al.
Publicado: (2021)

SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2016)
por: de las Peñas, R., et al.
Publicado: (2016)

SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2021)
por: Majem, Margarita, et al.
Publicado: (2022)

Comparison of application of 2013 ACC/AHA guideline and 2011 European Society of Cardiology guideline for the management of dyslipidemias for primary prevention in a Turkish cohort
por: Yılmaz, Mustafa, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_okia0rrv24e2q154nf9d5dl80q